NO20001514D0 - Vitronectin receptor antagonist - Google Patents
Vitronectin receptor antagonistInfo
- Publication number
- NO20001514D0 NO20001514D0 NO20001514A NO20001514A NO20001514D0 NO 20001514 D0 NO20001514 D0 NO 20001514D0 NO 20001514 A NO20001514 A NO 20001514A NO 20001514 A NO20001514 A NO 20001514A NO 20001514 D0 NO20001514 D0 NO 20001514D0
- Authority
- NO
- Norway
- Prior art keywords
- receptor antagonist
- vitronectin receptor
- vitronectin
- antagonist
- receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5983297P | 1997-09-24 | 1997-09-24 | |
| PCT/US1998/019949 WO1999015170A1 (en) | 1997-09-24 | 1998-09-24 | Vitronectin receptor antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001514L NO20001514L (en) | 2000-03-23 |
| NO20001514D0 true NO20001514D0 (en) | 2000-03-23 |
Family
ID=22025570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001514A NO20001514D0 (en) | 1997-09-24 | 2000-03-23 | Vitronectin receptor antagonist |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1017387A4 (en) |
| JP (1) | JP2002528380A (en) |
| KR (1) | KR20010024247A (en) |
| CN (1) | CN1273529A (en) |
| AU (1) | AU9577498A (en) |
| BR (1) | BR9813208A (en) |
| CA (1) | CA2303846A1 (en) |
| HU (1) | HUP0003949A2 (en) |
| IL (1) | IL135189A0 (en) |
| NO (1) | NO20001514D0 (en) |
| PL (1) | PL339413A1 (en) |
| TR (1) | TR200000792T2 (en) |
| WO (1) | WO1999015170A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU747503B2 (en) | 1999-02-03 | 2002-05-16 | Merck & Co., Inc. | Benzazepine derivatives as alpha-V integrin receptor antagonists |
| US6514964B1 (en) * | 1999-09-27 | 2003-02-04 | Amgen Inc. | Fused cycloheptane and fused azacycloheptane compounds and their methods of use |
| WO2002018377A1 (en) * | 2000-08-29 | 2002-03-07 | Pharmacia Corporation | Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| KR20030027106A (en) * | 2000-08-30 | 2003-04-03 | 파마시아 코포레이션 | Gem-substituted alpha v beta 3 integrin antagonists |
| US6531494B1 (en) | 2001-08-29 | 2003-03-11 | Pharmacia Corporation | Gem-substituted αvβ3 antagonists |
| KR100861466B1 (en) | 2001-04-24 | 2008-10-02 | 메르크 파텐트 게엠베하 | Combination therapy using anti-angiogenic agents and tnf? |
| KR20040058229A (en) | 2001-10-22 | 2004-07-03 | 더 스크립스 리서치 인스티튜트 | Antibody targeting compounds |
| UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| ES2521679T3 (en) | 2006-01-18 | 2014-11-13 | Merck Patent Gmbh | Specific therapy using integrin ligands for cancer treatment |
| KR20090108713A (en) | 2007-01-18 | 2009-10-16 | 메르크 파텐트 게엠베하 | Specific therapy and medicament using integrin ligands for treating cancer |
| ES2428896T3 (en) * | 2007-11-16 | 2013-11-12 | Ube Industries, Ltd. | Benzacepinone compound |
| EP2257538B1 (en) * | 2008-03-06 | 2016-04-27 | GlaxoSmithKline LLC | Process for the preparation of benzodiazepine derivatives |
| WO2010093706A2 (en) | 2009-02-10 | 2010-08-19 | The Scripps Research Institute | Chemically programmed vaccination |
| AU2010231631A1 (en) | 2009-03-30 | 2011-11-10 | Ube Industries, Ltd. | Pharmaceutical composition for treatment or prevention of ophthalmic diseases |
| JP5572996B2 (en) * | 2009-05-15 | 2014-08-20 | 宇部興産株式会社 | Medicine containing benzazepinone compound as active ingredient |
| BRPI1011206A2 (en) | 2009-05-25 | 2016-03-15 | Merck Patent Gmbh | continuous administration of integrin ligands to treat cancer |
| CN103864765B (en) * | 2014-03-05 | 2016-02-10 | 天津药物研究院 | Benzazepine analog derivative containing five-membered ring, Preparation Method And The Use |
| ES2864079T3 (en) | 2014-05-30 | 2021-10-13 | Pfizer | Carbonitrile derivatives as selective androgen receptor modulators |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA955391B (en) * | 1994-06-29 | 1996-02-09 | Smithkline Beecham Corp | Vitronectin receptor antagonists |
| UA60311C2 (en) * | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Vitronectin receptor antagonists |
| WO1998015278A1 (en) * | 1996-10-07 | 1998-04-16 | Smithkline Beecham Corporation | Method for stimulating bone formation |
-
1998
- 1998-09-24 BR BR9813208-3A patent/BR9813208A/en not_active Application Discontinuation
- 1998-09-24 PL PL98339413A patent/PL339413A1/en unknown
- 1998-09-24 AU AU95774/98A patent/AU9577498A/en not_active Abandoned
- 1998-09-24 CA CA002303846A patent/CA2303846A1/en not_active Abandoned
- 1998-09-24 CN CN98809495A patent/CN1273529A/en active Pending
- 1998-09-24 EP EP98949454A patent/EP1017387A4/en not_active Withdrawn
- 1998-09-24 IL IL13518998A patent/IL135189A0/en unknown
- 1998-09-24 WO PCT/US1998/019949 patent/WO1999015170A1/en not_active Application Discontinuation
- 1998-09-24 JP JP2000512539A patent/JP2002528380A/en not_active Withdrawn
- 1998-09-24 TR TR2000/00792T patent/TR200000792T2/en unknown
- 1998-09-24 KR KR1020007003088A patent/KR20010024247A/en not_active Application Discontinuation
- 1998-09-24 HU HU0003949A patent/HUP0003949A2/en unknown
-
2000
- 2000-03-23 NO NO20001514A patent/NO20001514D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1017387A1 (en) | 2000-07-12 |
| IL135189A0 (en) | 2001-05-20 |
| KR20010024247A (en) | 2001-03-26 |
| JP2002528380A (en) | 2002-09-03 |
| EP1017387A4 (en) | 2004-08-18 |
| AU9577498A (en) | 1999-04-12 |
| PL339413A1 (en) | 2000-12-18 |
| NO20001514L (en) | 2000-03-23 |
| BR9813208A (en) | 2000-08-22 |
| TR200000792T2 (en) | 2000-09-21 |
| HUP0003949A2 (en) | 2001-10-28 |
| CA2303846A1 (en) | 1999-04-01 |
| CN1273529A (en) | 2000-11-15 |
| WO1999015170A1 (en) | 1999-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9712248A (en) | Vitronectin receptor antagonist | |
| NO965608D0 (en) | Vitronectin receptor antagonists | |
| NO993350D0 (en) | Vitronectin receptor antagonists | |
| NO983001D0 (en) | Vitronectin receptor antagonists | |
| NO983003D0 (en) | Vitronectin receptor antagonists | |
| NO983002D0 (en) | Vitronectin receptor antagonists | |
| DE69812096T2 (en) | NEUROPEPTID Y RECEPTOR ANTAGONISTS | |
| EP1000031A4 (en) | Vitronectin receptor antagonist | |
| NO20001100D0 (en) | IL-8 receptor antagonists | |
| NO20001514D0 (en) | Vitronectin receptor antagonist | |
| NO20001515D0 (en) | Vitronectin receptor antagonist | |
| NO20004503D0 (en) | Vitronectin receptor antagonists | |
| NO20001407D0 (en) | Vitronectin receptor antagonists | |
| ID24726A (en) | TROMBIN RECEPTOR ANTAGONISTS | |
| ATE381330T1 (en) | IL-8 RECEPTOR ANTAGONISTS | |
| ATE277043T1 (en) | VITRONECTIN RECEPTOR ANTAGONIST | |
| ATE303370T1 (en) | IL-8 RECEPTOR ANTAGONISTS | |
| DE69824837D1 (en) | IL-8 RECEPTOR ANTAGONISTS | |
| NO20021113D0 (en) | Vitronectin receptor antagonists | |
| NO20010620D0 (en) | Vitronectin receptor antagonists | |
| DE69830671D1 (en) | Integrin receptor Antagonist | |
| DK1218005T3 (en) | Vitronectin receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |